• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET Back to Search Results
Catalog Number 000000000000010220
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bruise/Contusion (1754); Fall (1848); Loss of consciousness (2418)
Event Date 10/08/2014
Event Type  Injury  
Event Description
The customer reported that a patient underwent a red blood cell exchange (rbcx) procedure.After discharge from the unit, the patient fainted on the way home.The patient had some facial bruising and scrapes and was unsure if he hit his head.Patient was seen in the emergency department and received a head ct scan and admitted overnight for observation.Per the customer, the patient completed the procedure with no complications and the patient was observed by the nursing staff for approximately 20 minutes post procedure.The patient is instable condition and did not require follow-up.The disposable kit is not available for return because it was discarded by the customer.This report is being filed due to medical intervention in the form of head ct and overnight hospitalization.
 
Manufacturer Narrative
Investigation is in process.A follow-up report will be provided.
 
Manufacturer Narrative
Investigation: a review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to the reaction the patient experienced.The run data file (rdf) was analyzed for this event.Based on the information available in the run data file, the spectra optia system operated as intended.There is no indication in the run data file of a clear root cause for the patient fainting following the procedure.Per the therapeutic apheresis handbook: a physician's reference, 2nd edition, first time procedure patients reactions may occur in approximately 4.8% of procedures, and 1.2% of procedure patients experience reactions to citrate, based on the results of a survey of therapeutic procedures.Of these reactions, most were mild and well tolerated.The spectra optia system has many safety features.However, a patient reaction can occur rapidly.Therefore, it is imperative that the operator continuously monitor the patient and the system throughout the procedure.Root cause: this disposable set was unavailable for specific root cause analysis.Based on information provided by the customer, it is possible that the patient exhibited an allergic reaction to acd-a and/or eto.
 
Manufacturer Narrative
This record was identified during a retrospective review of mdr's, per fda request, to identify records in which a serious injury or medical intervention occurred, but the type of reportable event was not indicated as a serious injury of the mdr form.This supplement is being filed to modify information per fda request.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
jessica kim
10811 w. collins ave
lakewood, CO 80215
3032314812
MDR Report Key4224939
MDR Text Key19802904
Report Number1722028-2014-00438
Device Sequence Number1
Product Code LKN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BK140151
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 10/10/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/01/2016
Device Catalogue Number000000000000010220
Device Lot Number09W3117
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/20/2015
Initial Date FDA Received11/04/2014
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received01/20/2015
02/03/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/17/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age18 YR
Patient Weight63
-
-